Oncotelic Therapeutics Shares Groundbreaking Discovery In Pediatric Brainstem Tumors Demonstrating Potential For New Cancer Immunotherapy Treatments

Oncotelic Therapeutics OTLC, a therapeutics company with a focus on cancer and viral infection treatments, recently published a foundational discovery in pediatric brainstem tumors. The study showed that levels of two specific molecules – Transforming Growth Factor Beta 2 (TGF-B2) and Interferon…#interferon #ifngr2 #diffusemidlineglioma #vuongtrieu #oncotelic #sapubiosciences #sandiego #dipg #fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news